Clinical Trial Update: Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and effectiveness of raltegravir plus darunavir/ritonavir in treatment-naive HIV-1 infections; completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-1 Infections

Drugs mentioned

• Raltegravir (raltegravir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infections | Phase 2 | Status: COMPLETED | Results posted: 2011-10-10